Publikationen, an denen er mitarbeitet Maria José Sáez Lara (19)

2023

  1. From Non-Alcoholic Fatty Liver Disease to Liver Cancer: Microbiota and Inflammation as Key Players

    Pathogens, Vol. 12, Núm. 7

2022

  1. Editorial: Molecular and cellular aspects of regulatory and subjacent mechanisms in host/microbiota association and its involvement in cancer

    Frontiers in Cell and Developmental Biology

2021

  1. Bifidobacterium breve CNCM i-4035, lactobacillus paracasei cncm i-4034 and lactobacillus rhamnosus cncm i-4036 modulate macrophage gene expression and ameliorate damage markers in the liver of zucker-leprfa/fa rats

    Nutrients, Vol. 13, Núm. 1, pp. 1-14

  2. Mapping the entire functionally active endometrial microbiota

    Human Reproduction, Vol. 36, Núm. 4, pp. 1021-1031

  3. NAIP expression increases in a rat model of liver mass restoration

    Journal of Molecular Histology, Vol. 52, Núm. 1, pp. 113-123

2020

  1. New opportunities for endometrial health by modifying uterine microbial composition: Present or future?

    Biomolecules, Vol. 10, Núm. 4

2019

  1. Association of breast and gut microbiota dysbiosis and the risk of breast cancer: A case-control clinical study

    BMC Cancer, Vol. 19, Núm. 1

  2. Edulcorantes y microbiota

    Revista española de nutrición humana y dietética, Vol. 23, Núm. 1, pp. 24-25

  3. Edulcorantes y microbiota

    Revista Espanola de Nutricion Humana y Dietetica, Vol. 23, pp. 24-25

  4. Effects of Sweeteners on the Gut Microbiota: A Review of Experimental Studies and Clinical Trials

    Advances in Nutrition

  5. Microbial population changes and their relationship with human health and disease

    Microorganisms, Vol. 7, Núm. 3

  6. Passive commuting and higher sedentary time is associated with vitamin D deficiency in adult and older women: Results from Chilean National Health Survey 2016–2017

    Nutrients, Vol. 11, Núm. 2

  7. Use of probiotics in inflammatory bowel disease

    Microbiome and Metabolome in Diagnosis, Therapy, and other Strategic Applications (Elsevier), pp. 149-154

2017

  1. Adamdec1, Ednrb and Ptgs1/Cox1, inflammation genes upregulated in the intestinal mucosa of obese rats, are downregulated by three probiotic strains

    Scientific Reports, Vol. 7, Núm. 1

  2. Gene expression profiling in the intestinal mucosa of obese rats administered probiotic bacteria

    Scientific Data, Vol. 4

2016

  1. Effects of probiotics and synbiotics on obesity, insulin resistance syndrome, type 2 diabetes and non-alcoholic fatty liver disease: A review of human clinical trials

    International Journal of Molecular Sciences, Vol. 17, Núm. 6

2015

  1. Pyrosequencing analysis reveals changes in intestinal microbiota of healthy adults who received a daily dose of immunomodulatory probiotic strains

    Nutrients, Vol. 7, Núm. 6, pp. 3999-4015

  2. The role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: A systematic review of randomized human clinical trials

    BioMed Research International, Vol. 2015

2014

  1. Effects of Lactobacillus paracasei CNCM I-4034, Bifidobacterium breve CNCM I-4035 and Lactobacillus rhamnosus CNCM I-4036 on hepatic steatosis in Zucker rats

    PLoS ONE, Vol. 9, Núm. 5